Updated safety and clinical activity of durvalumab monotherapy in previously treated patients with stage IIIB/IV NSCLC Meeting Abstract
| Authors: | Balmanoukian, A. S.; Antonia, S. J.; Hwu, W. J.; Hamid, O.; Gutierrez, M.; Jamal, R.; Jerusalem, G. H. M.; Ahn, M. J.; Kim, D. W.; Cunningham, D.; Kim, S. W.; Brahmer, J. R.; Lutzky, J.; Weiss, J.; Jin, X.; Antal, J.; Gupta, A. K.; Segal, N. H. |
| Abstract Title: | Updated safety and clinical activity of durvalumab monotherapy in previously treated patients with stage IIIB/IV NSCLC |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 470s |
| Language: | English |
| ACCESSION: | WOS:000411932202145 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.9085 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9085 -- Source: Wos |
